All lobbying filings
STANTON PARK GROUP
Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Global biotechnology company
Filing
1st Quarter - Report
Lobbying activity
1
Patient access to rare and orphan disease therapeutics; FDA regulatory pathways for pharmaceuticals; Awareness of Cystic Fibrosis and Sickle Cell Disease; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; HR 1227 and S. 375